Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Bimekizumab effectively treated a man's chronic beard hair loss.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Combining fractional CO2 laser or microneedling with 5-FU is more effective and safer for treating vitiligo.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

The combination therapy was effective and well-tolerated, especially in young patients.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

These hair loss conditions might be part of a spectrum, not separate issues.

Fetuin A may increase collagen production and promote scarring.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Fetuin A, Anigozanthos Flavidus extract, and Ovol2 affect wound healing and skin regeneration.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.